Specialty Infusion only administers FDA approved brand and generic pharmaceuticals sourced from reputable U.S. distributors.
and Injection Treatments
Aduhelm is the first disease modifying, FDA approved therapy indicated for certain patients with Alzheimer’s Disease (AD).
BENLYSTA® (Belimumab) is an immunosuppressive drug used to treat active Systemic Lupus Erythematosus.
CIMZIA® (Certolizumab pegol) is an anti-inflammatory drug used to treat various autoimmune diseases.
ENTYVIO® (Vedolizumab) is an anti-inflammatory drug used to treat Inflammatory Bowel Diseases.
FABRAZYME® (Agalsidase beta) is used in the treatment of Fabry Disease by replacing a missing enzyme that lowers the amount of GL-3 being deposited in the lining of blood vessels.
FASENRA® (Benralizumab) is an immunosuppressive drug that is used as an add-on maintenance therapy for patients with severe Eosinophilic Asthma.
GIVLAARI is indicated for the treatment of adults with acute hepatic porphyria (AHP)
Intralipid® is used as a source of calories and essential fatty acids to help treat a wide array of diseases.
Immune globulin (IG) therapy is used to treat the following conditions: Primary Immunodeficiency, Multifocal Motor Neuropathy, Primary Humoral
KRYSTEXXA® (Pegloticase) is a drug used in the treatment of severe, refractory, chronic gout. It metabolizes uric acid to allantoin making it more water soluble increasing its excretion.
Lemtrada® (Alemtuzumab) is a medication used to treat adults with relapsing forms of multiple sclerosis (MS).
NAD+ stands for nicotinamide adenine dinucleotide, and it is a coenzyme found in all living cells. It is considered to be an anti-aging molecule, and it promotes a healthy lifestyle and a prolonged lifespan
Nulojix is a biologic infusion therapy that helps prevent transplant rejection in adults who have received a kidney transplant.
OCREVUS® (Ocrelizumab) is an immunosuppressive drug used in the treatment of Relapsing and Primary Progressive Multiple Sclerosis.
ONPATTRO® (Patisiran) is a double-stranded small interfering ribonucleic acid targeted to hepatocytes for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.
ORENCIA® (Abatacept) is an immunosuppressive drug used in the treatment of various types of arthritis.
RADICAVA® (Edaravone) is a prescription drug used for the treatment of Amyotrophic Lateral Sclerosis.
REMICADE® (Infliximab) is an immunosuppressive drug that is used in the treatment of Inflammatory Bowel Disease, as well as other autoimmune diseases.
RENFLEXIS® (Infliximab-abda) a biosimilar to Remicade, is a drug used in the treatment of Inflammatory Bowel Disease, as well as other autoimmune diseases.
RITUXAN® (Rituximab) is a prescription medicine used to treat adults with various forms of immunodeficient diseases.
SIMPONI ARIA® (Golimumab) is an immunosuppressive drug that reduces the body’s inflammation to treat various autoimmune diseases.
Soliris® (Eculizumab) is a monoclonal antibody in the category of immunosuppressive drugs used for the treatment of hemolytic blood disorders.
SOLU-MEDROL® (Methylprednisolone) is a steroid that is intravenously administered for the treatment of inflammation, severe allergies and flares of chronic illnesses.
STELARA IV® (Ustekinumab) is an immunosuppressive drug that reduces inflammation in the body due to various autoimmune diseases.
STELARA SQ® (Ustekinumab) is an immunosuppressive drug that reduces inflammation in the body due to various autoimmune diseases.
TEPEZZA® (teprotumumab-trbw) is a prescription medicine used in the treatment of Thyroid Eye Disease (TED). It reduces the signs and symptoms of TED, including eye bulging, double vision, eye pain, redness, and swelling.
TYSABRI® (Natalizumab) is a prescription medicine used to treat adults with relapsing forms of Multiple Sclerosis.
UPLIZNA is a prescription medicine used to treat adults with neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 (AQP4) antibody positive.
VPRIV® (Velaglucerase alfa) is a long-term enzyme replacement therapy for patients with type 1 Gaucher disease.
VYVGART is a neonatal Fc receptor blocker indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive.
XOLAIR® (Omalizumab) is an immunosuppressive drug used to treat moderate to severe persistent allergic asthma not controlled by inhaled corticosteroids.